Serologic status and safety of inactivated Covid‐19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection

Affiliations

Fuchen Liu: The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Third Affiliated HospitalSecond Military Medical University, Naval Medical University ShanghaiP. R. China
Xiaochen Feng: The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Third Affiliated HospitalSecond Military Medical University, Naval Medical University ShanghaiP. R. China
Jin Du: The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Third Affiliated HospitalSecond Military Medical University, Naval Medical University ShanghaiP. R. China
Minghao Ruan: The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Third Affiliated HospitalSecond Military Medical University, Naval Medical University ShanghaiP. R. China
Hui Liu: The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Third Affiliated HospitalSecond Military Medical University, Naval Medical University ShanghaiP. R. China

Abstract

No abstracts available.

ISSN: 2523-3548 (Online)
Publisher: Wiley
Country of publisher: Australia
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://onlinelibrary.wiley.com/journal/25233548